Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study

Fig. 1

Trajectory of plasma BDNF levels over time (n = 51). a Classified based on the entire patient pool; b classified based on overall cognition status; c classified based on BDNF rs6265 genotypes; d the Friedman test was used to evaluate changes in the plasma BDNF levels over time, e Post-hoc analysis was conducted using the Wilcoxon signed rank test for pair-wise comparisons. * P values are significant if they are less than 0.0167

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us